Skip to main content

US ClosedU.S. Closed

KYMR: Kymera Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics.

52W Range

87thpctl

Volume

0.55×avg

Market Cap

9.72BUSD

P/E Ratio

-36.4TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Kymera Therapeutics, Inc.

KYMRNASDAQ Global Market·USD·Closed

Kymera Therapeutics, Inc.

KYMRNASDAQ·USD·Closed

$118.15

−1.73%

$118.15

−$2.08 (1.73%)

52W Range

87thpctl

Volume

0.55×avg

Mkt Cap

9.72BUSD

P/E

-36.4TTM

Div Yield

–ann